Lupin executes BTA for transfer of API R&D Division to Lupin Manufacturing Solutions

01 Jul 2025 Evaluate

Lupin has executed a Business Transfer Agreement (BTA) for transfer of its API R&D Division situated at Pune, to Lupin Manufacturing Solutions, a wholly owned subsidiary of the Company, on a slump sale basis. In terms of the BTA, the said transaction has been completed and transfer of API R&D Division is effective from July 01, 2025.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2103.30 -8.70 (-0.41%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×